Public trial registry of the CCC-Munich

Trial AbbVIe M14-011 (Brightness)

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AbbVIe M14-011 (Brightness)
World
Full title
:

A Randomized, Placebo-Controlled, Double-Blind Phase III Study Evaluating the Safety and Efficacy of the Addition of a PARP Inhibitor Plus Carboplatin Versus the Addition of Carboplatin in Combination with Standard Neoadjuvant Chemotherapy Versus Standard Neoadjuvant Chemotherapy in Subjects with Early Stage Triple Negative Breast Cancer (TNBC)

World
Responsible organization
:
Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- C50.9 Brustdrüse, nicht näher bezeichnet
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
World
Therapy
:

Zielgerichtet - Therapieart: neoadjuvant

Participants
Function Prename Surname Organization
World Responsible contact Stefan Paepke Keine Organisationseinheit angegeben Magnifier